Teva launches generic version of Prevpac Kit

Drug maker announces introduction of generic antibiotic treatment regimen

NORTH WALES, Pa. — Teva Pharmaceutical Industries has introduced a generic version of an antibiotic drug kit, the company said.

Teva, through U.S. subsidiary Teva Pharmaceuticals, announced the introduction of 30-mg lansoprazole delayed-release capsules, 500-mg amoxicillin capsules and 500-mg clarithromycin tablets. The treatment is packaged in 14 cards with eight pills, designed for 14 days of treatment.

The treatment is a generic version of Takeda's Prevpac Kit.


Login or Register to post a comment.